356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease
No abstract is available for this record.
Bibliographic context
- Journal
- Biological Psychiatry
- Date
- 2026-04-24
- Source
- OpenAlex
- PubMed
- Unavailable
Authors
Ellen BradleyD Parker KelleyMartin PicardBalazs SzigetiKimberly SakaiGisele FernandesJill OstremCaroline TannerPatrick FinleyConnie LudwigKatiah LlerenaZach BusbyAmber McKernanJose Rafael ZuzuarreguiMeredith BockAliss WangAndrew PennJosh WoolleyAoife O'Donovan
Watch author
Topics and keywords
psilocybin Chronic PainPharmacologyBiomarkersMitochondrial FunctionClinical TrialInflammation Clinical Trial MedicineClinical trialDiseasePsilocybinInflammationPharmacologyInternal medicineMitochondrionPharmacotherapyImmunologyBioinformaticsPsychedelics and Drug StudiesCannabis and Cannabinoid ResearchPain Management and Placebo Effect
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.